Schematic summary of the proposed role of Epac1 in the regulation of myofilament function. by Yoshiki Ohnuki (576298)

Subjects:

Functional characterization of skinned myocardium prepared from Epac1TG. by Yoshiki Ohnuki (576298)

Subjects:

Epac activation increased RLC phosphorylation via PLC/PKC. by Yoshiki Ohnuki (576298)

Subjects:

Phosphorylation status of myofilament proteins prepared from Epac1TG. by Yoshiki Ohnuki (576298)

Subjects:

Epac1 expression in the hearts of NTG and Epac1TG. by Yoshiki Ohnuki (576298)

Subjects:

Pairwise comparison of adult longevity across treatments. P-values from pairwise comparisons between control conditions and irradiation doses. Values in boldface indicate significa... by Flavia Cerasti (21655934)

Subjects:

Prevalence of <i>Anaplasma</i> spp. and <i>A. ovis</i> among the screened goat breeds enrolled from three sampling districts in Punjab during the present study. % prevalence of eac... by Sumaira Sumaira (21453523)

Subjects:

Factors associated with first-time HCV testing. by Bao Vu Ngoc (14551955)

Subjects:

Effects of pre-medication and warming device on systolic (SAP), diastolic (DAP) and mean (MAP) arterial pressures in dogs following pre-medication, induction and inhalant anesthesi... by Jacob P. Rastas (20642173)

Subjects:

Change in rectal temperature following pre-medication, induction and inhalant anesthesia. by Jacob P. Rastas (20642173)

Subjects:

Effects of pre-medication and warming device on heart rate (HR) assessed by pulse oximetry in dogs following pre-medication, induction and inhalant anesthesia. by Jacob P. Rastas (20642173)

Subjects:

S1 File - by Jacob P. Rastas (20642173)

Subjects:

Times to tracheal extubation, sternal recumbency and standing (minutes) following inhalant anesthesia and final rectal temperatures (°C) in each premedication-treatment group. by Jacob P. Rastas (20642173)

Subjects:

AVAcore placement. by Jacob P. Rastas (20642173)

Subjects:

No significant differences in the numbers of eggs between Mst1^+/+ and Mst1^ΔM/ΔM mice. by Jianyang Li (461703)

Change in Watt’s Connectedness Scale, Subscales by Treatment Group. by Benjamin R. Lewis (22279166)

Subjects:

Primary and secondary efficacy end points (intention-to-treat population). by Benjamin R. Lewis (22279166)

Subjects:

Demographic and clinical characteristics of participants at baseline. by Benjamin R. Lewis (22279166)

Subjects:

Study-related adverse events. by Benjamin R. Lewis (22279166)

Subjects:

Study flow chart. by Benjamin R. Lewis (22279166)

Subjects: